topotecan has been researched along with Female Genital Neoplasms in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Aljumaily, R; Burris Iii, HA; Johnson, ML; Jones, SF; Patel, MR; Spigel, DR | 1 |
| Bhowmik, S; Chan, JK; Chow, S; Coleman, RL; Kapp, DS; Mann, A | 1 |
| Abu-Rustum, NR; Andikyan, V; Barakat, RR; Chi, DS; Khoury-Collado, F; Konner, JA; O'Cearbhaill, RE; Sandadi, S; Sonoda, Y; Tew, WP | 1 |
| Harstead, KE; Stewart, CF; Throm, SL; Tillmanns, TD; Turner, DC | 1 |
| Di Vagno, G; Lorusso, D; Mainenti, S; Masciullo, V; Pietragalla, A; Scambia, G | 1 |
| Fleming, GF; Temkin, SM; Yamada, SD | 1 |
| Bonnar, J; Gleeson, NC; McGuinness, EP; O'Toole, SA; Sheppard, BL; Yoneda, M | 1 |
| Alberts, DS; Berek, JS; Garcia, DJ; Gold, MA; Hallum, AV; Walker, JL | 1 |
| Berkowitz, R; Campos, S; Colella, T; Duska, L; Fuller, A; Gore, S; Lee, H; Matulonis, U; Roche, M; Seiden, MV | 1 |
| Atkinson, T; Berkowitz, RS; Campos, SM; Fuller, AF; Goodman, A; Krasner, C; Lee, H; Matulonis, UA; Penson, RT; Seiden, MV | 1 |
| McNeil, C | 1 |
| Gutzler, F | 1 |
| Sugiyama, T; Ushijima, K; Yakushiji, M | 1 |
| Coleman, RL; Miller, DS | 1 |
4 review(s) available for topotecan and Female Genital Neoplasms
| Article | Year |
|---|---|
Metastatic gynecologic malignancies: advances in treatment and management.
Topics: Doxorubicin; Female; Genital Neoplasms, Female; Humans; Neoplasm Metastasis; Poly(ADP-ribose) Polymerase Inhibitors; Taxoids; Topotecan | 2018 |
Review role of topotecan in gynaecological cancers: current indications and perspectives.
Topics: Antineoplastic Agents; Drug Interactions; Female; Genital Neoplasms, Female; Humans; Topotecan | 2010 |
[Promising new drugs for gynecological cancer].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Clinical Trials, Phase I as Topic; Cyclophosphamide; Docetaxel; Drug Administration Schedule; Female; Genital Neoplasms, Female; Humans; Irinotecan; Organoplatinum Compounds; Paclitaxel; Taxoids; Topotecan | 1997 |
Topotecan in the treatment of gynecologic cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Female; Genital Neoplasms, Female; Humans; Ovarian Neoplasms; Topoisomerase I Inhibitors; Topotecan; Uterine Cervical Neoplasms | 1997 |
5 trial(s) available for topotecan and Female Genital Neoplasms
| Article | Year |
|---|---|
A Phase Ib Dose-Escalation Study of LCL161 Plus Oral Topotecan for Patients With Relapsed/Refractory Small Cell Lung Cancer and Select Gynecologic Malignancies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Genital Neoplasms, Female; Humans; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Small Cell Lung Carcinoma; Topotecan | 2023 |
A phase I study of weekly temsirolimus and topotecan in the treatment of advanced and/or recurrent gynecologic malignancies.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Genital Neoplasms, Female; Humans; Infusions, Intravenous; Middle Aged; Neoplasm Recurrence, Local; Sirolimus; Topotecan | 2010 |
Amifostine pretreatment for protection against topotecan-induced hematologic toxicity: results of a multicenter phase III trial in patients with advanced gynecologic malignancies.
Topics: Adult; Aged; Amifostine; Antineoplastic Agents; Female; Genital Neoplasms, Female; Humans; Middle Aged; Neutropenia; Topotecan | 2003 |
A phase II trial of three sequential doublets for the treatment of advanced müllerian malignancies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous; Deoxycytidine; Doxorubicin; Drug Administration Schedule; Endometrial Neoplasms; Fallopian Tube Neoplasms; Female; Gemcitabine; Genital Neoplasms, Female; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Mixed Tumor, Mullerian; Ovarian Neoplasms; Peritoneal Neoplasms; Topotecan | 2003 |
Phase I trial of escalating doses of topotecan in combination with a fixed dose of pegylated liposomal doxorubicin in women with müllerian malignancies.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Female; Genital Neoplasms, Female; Humans; Infusions, Intravenous; Middle Aged; Mixed Tumor, Mullerian; Topotecan | 2004 |
5 other study(ies) available for topotecan and Female Genital Neoplasms
| Article | Year |
|---|---|
Feasibility of adjuvant chemotherapy after pelvic exenteration for gynecologic malignancies.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Deoxycytidine; Endometrial Neoplasms; Feasibility Studies; Female; Follow-Up Studies; Gemcitabine; Genital Neoplasms, Female; Humans; Irinotecan; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Pelvic Exenteration; Prognosis; Retrospective Studies; Survival Rate; Topotecan | 2013 |
Combination metronomic oral topotecan and pazopanib: a pharmacokinetic study in patients with gynecological cancer.
Topics: Administration, Oral; Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Chromatography, High Pressure Liquid; Female; Genital Neoplasms, Female; Humans; Indazoles; Middle Aged; Pyrimidines; Sulfonamides; Topotecan | 2013 |
The MTS assay as an indicator of chemosensitivity/resistance in malignant gynaecological tumours.
Topics: Antineoplastic Agents; Cell Survival; Cells, Cultured; Cisplatin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Therapy, Combination; Endometrial Neoplasms; Female; Fluorouracil; Genital Neoplasms, Female; Humans; Neoplasm Staging; Paclitaxel; Retrospective Studies; Tetrazolium Salts; Topotecan; Toxicity Tests; Treatment Outcome; Uterine Cervical Neoplasms | 2003 |
Topotecan: after FDA and ASCO, what's next?
Topics: Antineoplastic Agents; Camptothecin; Female; Genital Neoplasms, Female; Humans; Recurrence; Topotecan; United States; United States Food and Drug Administration | 1996 |
[New drugs. Topoisomerase inhibitors].
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Female; Genital Neoplasms, Female; Humans; Irinotecan; Structure-Activity Relationship; Topoisomerase I Inhibitors; Topotecan; Treatment Outcome | 1996 |